Skip to main content

2026 doctoral scholarship in pharmaceutical sciences - The Morris and Rosalind Goodman Family Foundation

The Morris and Rosalind Goodman Family Foundation scholarship program, established in 2023, aims to attract exceptional candidates from Québec, Canada, and abroad who wish to pursue a doctorate in pharmaceutical sciences at Université Laval’s Faculty of Pharmacy.

This prestigious scholarship supports innovative research projects along the entire pharmaceutical continuum, from the discovery of new drugs to their optimal use in the general population.

Deadlines | Decembre 7, 2026

Scholarship amount and duration

Amount: CAN$100,000 (CAN$12,500 per semester, or CAN$37,500 per year)
Duration: Up to eight semesters  

Additional funding for extra semesters may be provided by the research supervisor, if necessary. 

Eligibility

The scholarship is open to students who have been accepted into the pharmaceutical sciences or pharmacoepidemiology doctoral programs for the winter, summer, or fall 2027 semesters.

In order to be eligible for the scholarship, candidates must find a professor in the Faculty of Pharmacy willing to supervise their doctoral dissertation.

Eligibility is contingent on supervisor acceptance.

The Goodman scholarship is open to international students.

Research areas

The program covers all areas of pharmaceutical science in which the Faculty’s research teams are active, including:

  • Nanotechnologies  
  • Drug formulation
  • Drug target discovery
  • Pharmacogenomics
  • Repurposing of off-patent drugs
  • Applied pharmacokinetics for bioequivalence testing
  • Population health
  • Drug quality risk assessment
  • Pharmacoeconomics
  • Health information technologies and policies
  • Radiopharmacy and theranostics

Recipients

1 of 2

Ariane Lapointe-Belleau, 2024

Research supervisor: Professor Chantal Guillemette

Alain E. Andrea, 2025

Research supervisor: Professor Aline Hajj

Pursuing a doctorate at the Faculty of Pharmacy

To be eligible for the Goodman scholarship, you must be enrolled in the pharmaceutical sciences or pharmacoepidemiology doctoral programs.

These programs offer:

  • Personalized guidance from internationally recognized research teams
  • A multidisciplinary scientific environment
  • State-of-the-art research facilities
  • Access to an extensive network of national and international partnerships